Current Studies
Please get in touch with our Research department for further information regarding participating in a clinical trial. Lake Cumberland Rheumatology’s Research department can be reached by email at dwalker@lcrheumatology.com or by phone by dialing (502) 351-6983.
A Randomized, Double-Blind, Placebo-Controlled Phase 4 Clinical Trial to Evaluate the Long-Term Safety and Efficacy of Avacopan in Subjects With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Participants must be:
- 18 years of age or older
- diagnosed with ANCA Vasculitis
A Phase 4, Randomized, Double-Blind, Multicenter Non-inferiority Trial Evaluating the Efficacy and Safety of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks Compared with KRYSTEXXA Administered Every 2 Weeks with Co-Administration of Weekly Doses of Methotrexate, Followed by an Open-Label Extension, in Participants with Uncontrolled Refractory Gout (FORWARD II)
Participants must be:
- 18 years of age or older
- diagnosed with uncontrolled gout
A Randomized, Double-Blind, Parallel Group Placebo[1] Controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety, and Tolerability of Two Regiments of Ianalumab on Top of Standard-Of-Care Therapy with Patients with Systematic Lupus Erythematosus (SIRIUS-SLE 1)
Participants must be:
- 18 years of age or older
- diagnosed with Systemic Lupus Erythematosus for at least 6 months before screening
